Why Women in Their 40s Are Quitting Their Antidepressants After Hormone Therapy
A common pattern: women in their early 40s get prescribed SSRIs for what turns out to be hormonal anxiety. See the mechanism behind why bioidentical progesterone often addresses what antidepressants only partly cover, and how to evaluate it safely.
Progesterone vs Progestin: The One-Letter Difference That Could Define Your Treatment
Progesterone and progestins are not the same molecule. They bind receptors differently, affect breast tissue differently, and have different effects on sleep and mood. Here is what the difference means for your hormone therapy decision.
SHBG, Reverse T3, and DHEA-S: The Hormone Labs Hiding in Plain Sight
Standard physicals run a thin hormone panel. Three markers (SHBG, reverse T3, and DHEA-S) explain most of the symptoms patients feel when their bloodwork comes back “fine.” Here is what each one measures, why it matters, and what to ask for.
The State of Hormone Therapy in 2026: What the Clinical Evidence Shows About Optimization Outcomes
Where does hormone therapy actually stand in 2026? This breakdown of the clinical evidence covers what the major studies show about testosterone, estrogen, and optimization outcomes for men and women.
Testosterone Optimization for Men Over 40: Beyond the ‘Normal Range’
Your doctor says your testosterone is “normal,” but you feel exhausted, foggy, and out of shape. Learn why the standard reference range misses the mark and what optimization actually looks like.
The Science of Hormone Optimization: What Your Primary Care Doctor Isn’t Testing
Standard blood tests miss a lot. Learn which hormone markers actually matter and why your “normal” results might be hiding the real reason you feel exhausted.
